Floatz logo

Peripheral Blood Mononuclear Cell

Critical Limb Ischemia

Mahidol UniversityCell therapyPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Critical Limb Ischemia cohort.

Asset / SponsorPhaseRating
Pregabalin
Karolinska Institutet
Phase 4BB
TREPROSTINIL PHOSPHATE
United Therapeutics
Phase 3B
PCK-HGFX7
Helixmith Co., Ltd.
Phase 2B
TREPROSTINIL DIETHANOLAMINE
Southern Arizona Vascular Institute
Phase 2CCC
Pvgi.1
Phase 1CC
Endothelial Progenitor Cells
Allife Medical Science and Technology Co., Ltd.
Phase 1CC

Same molecule, other indications

Peripheral Blood Mononuclear Cell is also rated in:

ulcer of lower limbsDormant
BB
Indicative ·
64 / 100
View asset →
atherosclerosisDormant
B
Indicative ·
62 / 100
View asset →
amyotrophic lateral sclerosisDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →